Page 28 - Avoid Food and Drug Interactions
P. 28

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved.  Learning Objectives

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved.      Upon completion of this session, the learner will be able to….
                                                                                            1. Understand the value of optimal management of central venous access

                                                                                                 devices to reduce PN risk.
                                                                                            2. Recognize the impact of recent evidence related to risks and benefits

                                                                                                 of parenteral nutrition (PN).
                                                                                            3. Leverage new evidence to enhance nutritional support practices.

                                                                                                                                                                                                                    51

                                                                                            Outline

                                                                                            • Review the common “myths” related to PN use
                                                                                            • Address the role of catheter management to reduce risk
                                                                                            • Compare historical PN use to current PN use
                                                                                            • Discuss available lipid emulsions and possible benefits

                                                                                                                                                                                                                    52

                                                                                                                                                                       28
   23   24   25   26   27   28   29   30   31   32   33